AEMD
Price
$0.22
Change
-$0.00 (-0.00%)
Updated
Sep 27, 6:59 PM EST
35 days until earnings call
IDXX
Price
$436.86
Change
+$4.44 (+1.03%)
Updated
Sep 27, 6:59 PM EST
33 days until earnings call

Compare trend and price AEMD vs IDXX

Header iconAEMD vs IDXX Comparison
Open Charts AEMD vs IDXXBanner chart's image
Aethlon Medical
Price$0.22
Change-$0.00 (-0.00%)
Volume$32.77K
CapitalizationN/A
IDEXX Laboratories
Price$436.86
Change+$4.44 (+1.03%)
Volume$195.02K
CapitalizationN/A
View a ticker or compare two or three
AEMD vs IDXX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AEMD vs. IDXX commentary
Sep 28, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a Hold and IDXX is a StrongSell.

COMPARISON
Comparison
Sep 28, 2023
Stock price -- (AEMD: $0.22 vs. IDXX: $436.86)
Brand notoriety: AEMD and IDXX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AEMD: 70% vs. IDXX: 110%
Market capitalization -- AEMD: $5.44M vs. IDXX: $36.3B
AEMD [@Medical Specialties] is valued at $5.44M. IDXX’s [@Medical Specialties] market capitalization is $36.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEMD’s FA Score shows that 1 FA rating(s) are green whileIDXX’s FA Score has 1 green FA rating(s).

  • AEMD’s FA Score: 1 green, 4 red.
  • IDXX’s FA Score: 1 green, 4 red.
According to our system of comparison, IDXX is a better buy in the long-term than AEMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEMD’s TA Score shows that 4 TA indicator(s) are bullish while IDXX’s TA Score has 4 bullish TA indicator(s).

  • AEMD’s TA Score: 4 bullish, 3 bearish.
  • IDXX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AEMD is a better buy in the short-term than IDXX.

Price Growth

AEMD (@Medical Specialties) experienced а -12.00% price change this week, while IDXX (@Medical Specialties) price change was -4.06% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.19%. For the same industry, the average monthly price growth was -5.40%, and the average quarterly price growth was -8.84%.

Reported Earning Dates

AEMD is expected to report earnings on Nov 02, 2023.

IDXX is expected to report earnings on Oct 31, 2023.

Industries' Descriptions

@Medical Specialties (-2.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for AEMD with price predictions.
OPEN
A.I.dvisor published
a Summary for IDXX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IDXX($36.3B) has a higher market cap than AEMD($5.44M). IDXX YTD gains are higher at: 7.084 vs. AEMD (-20.116). IDXX has higher annual earnings (EBITDA): 1.16B vs. AEMD (-12.1M). IDXX has more cash in the bank: 133M vs. AEMD (12.9M). AEMD has less debt than IDXX: AEMD (1.14M) vs IDXX (1.15B). IDXX has higher revenues than AEMD: IDXX (3.51B) vs AEMD (574K).
AEMDIDXXAEMD / IDXX
Capitalization5.44M36.3B0%
EBITDA-12.1M1.16B-1%
Gain YTD-20.1167.084-284%
P/E RatioN/A45.87-
Revenue574K3.51B0%
Total Cash12.9M133M10%
Total Debt1.14M1.15B0%
FUNDAMENTALS RATINGS
AEMD vs IDXX: Fundamental Ratings
AEMD
IDXX
OUTLOOK RATING
1..100
5357
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10047
SMR RATING
1..100
9813
PRICE GROWTH RATING
1..100
9460
P/E GROWTH RATING
1..100
10051
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AEMD's Valuation (27) in the Medical Specialties industry is somewhat better than the same rating for IDXX (87). This means that AEMD’s stock grew somewhat faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (47) in the Medical Specialties industry is somewhat better than the same rating for AEMD (100). This means that IDXX’s stock grew somewhat faster than AEMD’s over the last 12 months.

IDXX's SMR Rating (13) in the Medical Specialties industry is significantly better than the same rating for AEMD (98). This means that IDXX’s stock grew significantly faster than AEMD’s over the last 12 months.

IDXX's Price Growth Rating (60) in the Medical Specialties industry is somewhat better than the same rating for AEMD (94). This means that IDXX’s stock grew somewhat faster than AEMD’s over the last 12 months.

IDXX's P/E Growth Rating (51) in the Medical Specialties industry is somewhat better than the same rating for AEMD (100). This means that IDXX’s stock grew somewhat faster than AEMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEMDIDXX
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
51%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend about 1 month ago
68%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 7 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
60%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDXC1.450.02
+1.40%
ChromaDex Corp
CFB10.060.09
+0.90%
CrossFirst Bankshares
BJ72.960.04
+0.05%
BJs Wholesale Club Holdings
HRMY33.75-0.25
-0.74%
Harmony Biosciences Holdings
WAVD0.24-0.02
-8.12%
WaveDancer

AEMD and

Correlation & Price change

A.I.dvisor tells us that AEMD and APDN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEMD and APDN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEMD
1D Price
Change %
AEMD100%
-0.14%
APDN - AEMD
33%
Poorly correlated
-2.77%
IDXX - AEMD
29%
Poorly correlated
+1.03%
INMD - AEMD
28%
Poorly correlated
+0.99%
NVRO - AEMD
26%
Poorly correlated
+1.22%
CSTL - AEMD
25%
Poorly correlated
+2.02%
More

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been closely correlated with RVTY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if IDXX jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+1.03%
RVTY - IDXX
69%
Closely correlated
+0.11%
COO - IDXX
66%
Closely correlated
-4.66%
IQV - IDXX
63%
Loosely correlated
+0.61%
HOLX - IDXX
63%
Loosely correlated
-0.94%
ISRG - IDXX
60%
Loosely correlated
+0.24%
More